B

Bent Ejlertsen

University of Copenhagen

ORCID: 0000-0001-8761-714X

Publishes on Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology. 423 papers and 22.9k citations.

423Publications

22.9kTotal Citations

Breast Cancer Treatment Studies HER2/EGFR in Cancer Research Cancer Treatment and Pharmacology Advanced Breast Cancer Therapies Estrogen and related hormone effects

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Aron Goldhirsch, Eric P. Winer, Alan S. Coates et al.|Annals of Oncology|2013

Cited by 3.7kOpen Access

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Alan S. Coates, Eric P. Winer, Aron Goldhirsch et al.|Annals of Oncology|2015

Cited by 1.8kOpen Access

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

Giuseppe Curigliano, Harold J. Burstein, Eric P. Winer et al.|Annals of Oncology|2017

Cited by 1.3kOpen Access

Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

Harold J. Burstein, Giuseppe Curigliano, Beat Thürlimann et al.|Annals of Oncology|2021

Cited by 794Open Access

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al.|The Lancet Oncology|2017

Cited by 589